Literature DB >> 16897083

Modification of small molecules by using cytochrome P450 expressed in Escherichia coli.

Tomohide Uno1, Atsushi Nakao, Satoko Masuda, Yuuki Taniguchi, Kengo Kanamaru, Hiroshi Yamagata, Masahiko Nakamura, Hiromasa Imaishi, Kiyoharu Oono.   

Abstract

We developed a system for bioconverting diverse compounds using P450s produced in Escherichia coli. Vectors for the expressing various P450 cDNAs quickly and easily in E. coli were developed by using several restriction enzyme sites. Three types of P450 (2C2, 2C29, and 2D22) were produced using these plasmids. Substrates were directly added to the incubation medium and metabolized. To obtain pure product from the medium, we first tried production of P450 in synthetic medium. The amount of another P450 2C43 produced in the synthetic medium was similar to the amount produced in Luria broth (LB) medium. Next, estradiol, a steroid, was added as a substrate, incubated, and the metabolite was extracted and analyzed by high-performance liquid chromatography. The metabolite extracted from synthetic medium was purer than that obtained from LB medium. Three P450s (2C29, 2C2, and 2A4) metabolized testosterone at different positions. P450 2C29 metabolized 7-ethoxycoumarin, androstendione, and dehydroepiandrosterone in this medium. P450s produced in the synthetic medium may be useful for producing various modified compounds for high-throughput screening.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897083     DOI: 10.1007/s10295-006-0146-8

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  28 in total

1.  Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  J Inorg Biochem       Date:  2000-08-31       Impact factor: 4.155

2.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

3.  Enzyme family-specific and activity-based screening of chemical libraries using enzyme microarrays.

Authors:  Daniel P Funeriu; Jörg Eppinger; Lucile Denizot; Masato Miyake; Jun Miyake
Journal:  Nat Biotechnol       Date:  2005-04-10       Impact factor: 54.908

4.  Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.

Authors:  Y Y Deeni; M J Paine; A D Ayrton; S E Clarke; R Chenery; C R Wolf
Journal:  Arch Biochem Biophys       Date:  2001-12-01       Impact factor: 4.013

5.  A new method for simultaneous purification of cytochrome b5 and NADPH-cytochrome c reductase from rat liver microsomes.

Authors:  T Omura; S Takesue
Journal:  J Biochem       Date:  1970-02       Impact factor: 3.387

Review 6.  Predicting the cytochrome P450 mediated metabolism of xenobiotics.

Authors:  K R Korzekwa; J P Jones
Journal:  Pharmacogenetics       Date:  1993-02

Review 7.  Progress in cytochrome P450 active site modeling.

Authors:  Carol A Kemp; Jean-Didier Maréchal; Michael J Sutcliffe
Journal:  Arch Biochem Biophys       Date:  2005-01-15       Impact factor: 4.013

Review 8.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature.

Authors:  D R Nelson; L Koymans; T Kamataki; J J Stegeman; R Feyereisen; D J Waxman; M R Waterman; O Gotoh; M J Coon; R W Estabrook; I C Gunsalus; D W Nebert
Journal:  Pharmacogenetics       Date:  1996-02

9.  Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.

Authors:  Patricia J Willy; Ian R Murray; Jing Qian; Brett B Busch; William C Stevens; Richard Martin; Raju Mohan; Sihong Zhou; Peter Ordentlich; Ping Wei; Douglas W Sapp; Robert A Horlick; Richard A Heyman; Ira G Schulman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

Review 10.  Cloning allergens via phage display.

Authors:  Claudio Rhyner; Michael Weichel; Sabine Flückiger; Stefanie Hemmann; Tamara Kleber-Janke; Reto Crameri
Journal:  Methods       Date:  2004-03       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.